Skip to Content

Mekinist

In the US, Mekinist (trametinib systemic) is a member of the drug class multikinase inhibitors and is used to treat Melanoma, Metastatic.

US matches:

UK matches:

Ingredient matches for Mekinist

Trametinib

Trametinib is reported as an ingredient of Mekinist in the following countries:

  • Canada
  • Croatia (Hrvatska)
  • Poland
  • Slovenia

Trametinib dimethyl sulfoxide (a derivative of Trametinib) is reported as an ingredient of Mekinist in the following countries:

  • Australia
  • Germany
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide